Skip to content
  • About
    • Supporter
    • Expert Index
    • Editorial Board
    • Editorial Team
    • Editorial Policy
  • Contact
  • Sign up

Visit

vjneurology logo
VJDementia
Logo
  • Home (current)
  • Diseases
    Alzheimer's Disease
    Dementia
    Dementia with Lewy Bodies
    Frontotemporal Dementia
    Vascular Dementia
    Mild Cognitive Impairment
    View all Diseases
  • Topics
    Diagnostics
    Biology
    Communication
    Treatment
    Care Practice
    Prevention
    View all Topics
  • Conferences
    CTAD 2022
    AAIC 2022
    EAN 2022
    ESOC 2022
    AAN 2022
    CONy 2022
    View all Conferences
  • Features
  • Podcasts
    • About
      • Supporter
      • Expert Index
      • Editorial Board
      • Editorial Team
      • Editorial Policy
    • Contact
    • Sign up

Pamela Lukasewicz Ferreira

Plasma versus neuroimaging biomarkers for Alzheimer’s disease clinical trials 4:07
Plasma versus neuroimaging biomarkers for Alzheimer’s disease clinical trials
Pamela Lukasewicz Ferreira • 3 Aug 2022
Research priorities to achieve widespread use of blood-based biomarkers in Alzheimer’s disease 2:55
Research priorities to achieve widespread use of blood-based biomarkers in Alzheimer’s disease
Pamela Lukasewicz Ferreira • 3 Aug 2022
Value of p-tau231 in early Alzheimer’s disease 2:46
Value of p-tau231 in early Alzheimer’s disease
Pamela Lukasewicz Ferreira • 3 Aug 2022
Alzheimer’s disease plasma biomarkers across the spectrum: which perform best? 2:09
Alzheimer’s disease plasma biomarkers across the spectrum: which perform best?
Pamela Lukasewicz Ferreira • 3 Aug 2022
Strengthening diversity in dementia biomarkers research 1:50
Strengthening diversity in dementia biomarkers research
Pamela Lukasewicz Ferreira • 16 Mar 2022
The use of Alzheimer’s disease plasma biomarkers in the clinic: further research needed 1:45
The use of Alzheimer’s disease plasma biomarkers in the clinic: further research needed
Pamela Lukasewicz Ferreira • 16 Mar 2022
Upcoming plasma biomarkers for Alzheimer’s disease: Aβ, p-tau and GFAP 2:11
Upcoming plasma biomarkers for Alzheimer’s disease: Aβ, p-tau and GFAP
Pamela Lukasewicz Ferreira • 16 Mar 2022
Comparing the performance of novel biomarkers across the spectrum of Alzheimer’s disease 2:25
Comparing the performance of novel biomarkers across the spectrum of Alzheimer’s disease
Pamela Lukasewicz Ferreira • 16 Mar 2022
Plasma p-Tau181 and p-Tau231 offer complementary information in Alzheimer’s 3:13
Plasma p-Tau181 and p-Tau231 offer complementary information in Alzheimer’s
Pamela Lukasewicz Ferreira • 30 Jul 2021
APP/PS1 mutations associated with earlier cognitive decline in offspring rodents 1:44
APP/PS1 mutations associated with earlier cognitive decline in offspring rodents
Pamela Lukasewicz Ferreira • 30 Jul 2021
Journal Pages
  • Diseases
  • Topics
  • Medicines
  • Trials
  • Conferences
  • Features
Newsletter

Receive the latest news and videos from VJDementia via email

Sign up
Contact Us

Contact us for more information

mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJDementia logo
The content of VJDementia is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy